Saskatoon's only supervised consumption site, Prairie Harm Reduction (PHR), reported a threefold increase in overdose cases treated in 2025 compared to the previous year. The facility also supported 22 percent more individuals and performed over 150 overdose reversals.
These statistics underscore the severity of the toxic drug crisis in the city. Frontline workers note a rise in users knowingly consuming fentanyl due to its availability. Paramedics and drug testing at the site are credited with preventing a higher number of overdoses from becoming fatal.
Recent toxic drug alerts in Saskatoon have identified the presence of medetomidine, a veterinarian sedative that does not respond to naloxone. This poses a significant risk to unsuspecting users, particularly those who have not developed a tolerance to fentanyl.
Local officials are hosting a community meeting to discuss the site's impact on community safety, though PHR leadership expressed they were not formally invited to participate.